Published in
Taylor and Francis Group, Acta Oncologica, 9(59), p. 1123-1130, 2020
DOI: 10.1080/0284186x.2020.1775289
Links
Tools
An economic evaluation of eribulin for advanced breast cancer treatment based on the Southeast Netherlands advanced breast cancer registry
Journal article published in 2020 by
Xavier G. L. V. Pouwels 
,
Bram L. T. Ramaekers,
Sandra M. E. Geurts,
Frans Erdkamp,
Birgit E. P. J. Vriens,
Kirsten N. A. Aaldering,
Agnes J. van de Wouw,
M. W. Dercksen,
Tineke J. Smilde,
Natascha A. J. B. Peters,
J. M. G. H. van Riel,
Manon J. Pepels,
Jose Heijnen-Mommers,
Vivianne C. G. Tjan-Heijnen ,
Maaike de Boer
and other authors.
,
Bram L. T. Ramaekers,
Sandra M. E. Geurts,
Frans Erdkamp,
Birgit E. P. J. Vriens,
Kirsten N. A. Aaldering,
Agnes J. van de Wouw,
M. W. Dercksen,
Tineke J. Smilde,
Natascha A. J. B. Peters,
J. M. G. H. van Riel,
Manon J. Pepels,
Jose Heijnen-Mommers,
Vivianne C. G. Tjan-Heijnen ,
Maaike de Boer
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 